Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology
- PMID: 8624103
- DOI: 10.1111/j.1749-6632.1996.tb34398.x
Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology
Abstract
Brain imaging with functional techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) have been widely applied to the study of dementia. While the pattern of temporal and parietal hypometabolism and hypoperfusion have often been suggested to be of diagnostic utility in ascertaining that a dementia is due to Alzheimer's disease (AD), the exact sensitivity and specificity of this pattern in clinically important situations is unclear. These imaging findings have been of considerable interest, however, in describing the regional patterns of predilection in the disease. Evidence supports the contention that the earliest sites of functional impairment in AD are in the temporal lobes. Surprisingly, however, mesial temporal lobe hypometabolism was difficult to detect in a group of mildly demented AD patients in comparison to a group of healthy older subjects. These results suggest that simple use of mesial temporal lobe metabolic rates as a diagnostic for AD may not be fruitful, and that evaluation of the earliest stages of AD can be most productively studied by investigating healthy older individuals.
Similar articles
-
The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.Brain Res. 1993 Dec 3;629(2):189-98. doi: 10.1016/0006-8993(93)91320-r. Brain Res. 1993. PMID: 8111623
-
FDG PET imaging in patients with pathologically verified dementia.J Nucl Med. 2000 Nov;41(11):1920-8. J Nucl Med. 2000. PMID: 11079505
-
Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. doi: 10.1002/gps.4102. Epub 2014 Mar 29. Int J Geriatr Psychiatry. 2014. PMID: 24687634
-
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. doi: 10.1007/s00259-005-1762-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747152 Review.
-
SPECT and PET imaging in Alzheimer's disease.Ann Nucl Med. 2018 Nov;32(9):583-593. doi: 10.1007/s12149-018-1292-6. Epub 2018 Aug 20. Ann Nucl Med. 2018. PMID: 30128693 Review.
Cited by
-
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.J Alzheimers Dis. 2017;60(3):939-947. doi: 10.3233/JAD-161284. J Alzheimers Dis. 2017. PMID: 28984586 Free PMC article.
-
Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):73-80. doi: 10.1007/s00259-005-1874-0. Epub 2005 Sep 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16151770 Clinical Trial.
-
Magnetic resonance imaging of Alzheimer's disease.Eur Radiol. 2007 Feb;17(2):347-62. doi: 10.1007/s00330-006-0341-z. Epub 2006 Jul 25. Eur Radiol. 2007. PMID: 16865367 Review.
-
Method to correlate 1H MRSI and 18FDG-PET.Magn Reson Med. 2000 Feb;43(2):244-50. doi: 10.1002/(sici)1522-2594(200002)43:2<244::aid-mrm11>3.0.co;2-2. Magn Reson Med. 2000. PMID: 10680688 Free PMC article.
-
Early detection of patients in the pre demented stage of Alzheimer's disease: the Pre-Al Study.J Nutr Health Aging. 2009 Jan;13(1):21-6. doi: 10.1007/s12603-009-0004-2. J Nutr Health Aging. 2009. PMID: 19151903
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical